NCT00795951

Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents

Clinical Evaluation of T.R.U.E. TEST® Panel 1.1, 2.1 and 3.1: in Children and Adolescents

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 102 (actual)
• Sponsor: Allerderm · Industry
• Sex: All
• Age: 6 Years – 18 Years
• Healthy volunteers: Not accepted

Summary

Open, prospective, single-site, non-randomized study of the efficacy and safety of T.R.U.E. TEST allergens in children and adolescents ages 6-18.

Detailed description

Three T.R.U.E. TEST panels (1.1, 2.1 and 3.1) containing 28 allergens and a negative control will be applied to the skin on the subject's back and worn for approximately 48 hours. Patch test site skin reactions will be evaluated at days 2, 3 (+1), 7 and 21 following panel application

Conditions

• Dermatitis, Contact

Interventions

Type	Name	Description
BIOLOGICAL	T.R.U.E. Test	48 hour application of 28 allergens and negative control

Timeline

• Start date: 2008-11-01
• Primary completion: 2009-10-01
• Completion: 2009-11-01
• First posted: 2008-11-21
• Last updated: 2020-08-06
• Results posted: 2014-02-11

Locations

1 site across 1 country: United States